This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Amble Health para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A cash-pay telehealth platform using an external network of licensed clinicians and 503A/503B pharmacy partners. It advertises flat dose pricing and all-50-state clinical reach, but the exact pharmacy and public cancellation detail are limited.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes)
- Formats reviewed
- Injection
- Funding routes
- Private pay
- Service features
- Clinician support · Switching pathway · Home delivery
- Access check
- Provider coverage published; confirm treatment
- Evidence status
- Primary sources reviewed
- Research depth
- 2 cited sources · 2 medicine rows · 4 open checks
Recurring cost breakdown
- The program advertises medication, clinician review, and shipping within a plan price.
- “Same price every dose” is advertised, subject to pricing changes and promotion exclusions.
- The exact ordinary monthly total for each current formulation must be confirmed in the live checkout.
- No insurance billing pathway is central to the reviewed offer.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Personalized semaglutide treatment | Injection/formulation shown at checkout | Compounded; not FDA-approved | Flat-dose claim; verify live total |
| Personalized tirzepatide treatment | Injection/formulation shown at checkout | Compounded; not FDA-approved | Flat-dose claim; verify live total |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Amble says its physician network is licensed across all 50 states.
- Specific treatment availability can still be restricted by state, pharmacy, and clinical requirements.
Clinician access and follow-up cadence
- Independent licensed clinicians make prescribing decisions.
- Public pages do not promise a uniform live-visit or response-time cadence.
Pharmacy and fulfillment
- Amble describes a network using 503A and 503B pharmacy pathways.
- The marketing page does not publish one named dispenser for every state; verify the label, formulation, and facility.
Insurance and prior authorization
- The reviewed pathway is direct pay.
- Insurance prior authorization is not part of the main compounded offer.
Cancellation, refund, and commitment
- The complete cancellation cutoff and refund treatment were not clearly stated on the main public page.
- Confirm the next billing date and whether an order has been transmitted to the pharmacy before canceling.
Labs, monitoring, and dose management
- No universal included baseline or repeat lab panel was publicly confirmed.
- The treating clinician may request tests based on history.
Maintenance and switching
- An established-dose transfer remains subject to clinician review.
- Ask whether current records and last-dose timing can be reviewed before a new shipment is authorized.
Program snapshot
All-in cash-pay program
Profiled support: Ongoing clinician access, Simplified intake and fulfillment.
Cash pay
The reviewed program is positioned as cash pay.
Verify before purchase
Bask publicly names Amble as a platform customer. That does not identify the dispensing pharmacy; request it directly.
What the advertised program may include
- Online medical intake
- Clinician review
- Medication when prescribed
- Fulfillment as stated by the plan
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Comparing lower-cost access routes and recurring totals
- Ongoing clinician access
- Simplified intake and fulfillment
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Named dispensing pharmacy
- Current price table outside checkout
- Cancellation/refund cutoff
- Published follow-up and lab cadence
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
National access, flat-dose claim, clinician and pharmacy-network model
Billing, telehealth and cancellation terms to confirm